A retrospective cohort study assessing the association between risk of COVID-19 in nonimmune individuals and the number of their family members with known immunity from either a previous COVID-19 infection or full vaccination
Latest Information Update: 19 Oct 2021
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 19 Oct 2021 New trial record
- 11 Oct 2021 Results published in the JAMA Internal Medicine